Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001848280 | SCV002105996 | uncertain significance | Hereditary spastic paraplegia | 2017-05-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038700 | SCV003914600 | uncertain significance | not specified | 2023-03-13 | criteria provided, single submitter | clinical testing | The c.928A>G (p.T310A) alteration is located in exon 9 (coding exon 9) of the VPS37A gene. This alteration results from a A to G substitution at nucleotide position 928, causing the threonine (T) at amino acid position 310 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |